[1] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案[J]. 中华传染病杂志,2001,19 (1):56. [2] 全国腹水学术讨论会. 肝硬化腹水并发自发性细菌性腹膜炎的诊断参考标准[J]. 中华消化杂志,1989,35(6):91. [3] YEUNG E,YONG E,WONG F. Renal dysfunction in cirrhosis:diagnosis,treatment,and prevention[J]. Med Gen Med,2004,6(4):9. [4] 王洪,张波. 肝硬化合并感染危险因素的病例对照研究[J]. 中华医院感染学杂志,2006,16(1):36-37,46. [5] 王家珑. 重视肝硬化腹水的临床研究[J]. 中华消化杂志,2004,24(4):193-194. [6] 李顺良. 慢性重型肝炎和肝硬化并发自发性细菌性腹膜炎的临床分析[J]. 实用肝脏病杂志,2006,9(3):166-168. [7] WONG F,BLEI AT,BLENDIS LM,et al. A vasopressin receptor antagonist(VPA-985) improves serum sodium concentration in patients with hyponstremia: a multicenter,randomized,placebo-controlled trial[J]. Hepatology,2003,37:182-191. [8] JUNG ES,LEE JS,KIM MH,et al. Renal dysfunction after spontaneous bacterial peritonitis in cirrhosis:incidence and risk factors[J]. Korean J Gastroenterol,2006,48(6):401-407. [9] ARROYO V,JIMENEZ W. Clinical need for antidimetic hormone antagonists in cirrhosis[J]. Hepatology,2003,37:13-15. |